339 related articles for article (PubMed ID: 30892142)
1. The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program.
Kalna V; Yang Y; Peghaire CR; Frudd K; Hannah R; Shah AV; Osuna Almagro L; Boyle JJ; Göttgens B; Ferrer J; Randi AM; Birdsey GM
Circ Res; 2019 Apr; 124(9):1337-1349. PubMed ID: 30892142
[TBL] [Abstract][Full Text] [Related]
2. Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network.
Fish JE; Cantu Gutierrez M; Dang LT; Khyzha N; Chen Z; Veitch S; Cheng HS; Khor M; Antounians L; Njock MS; Boudreau E; Herman AM; Rhyner AM; Ruiz OE; Eisenhoffer GT; Medina-Rivera A; Wilson MD; Wythe JD
Development; 2017 Jul; 144(13):2428-2444. PubMed ID: 28536097
[TBL] [Abstract][Full Text] [Related]
3. Genomic Characterization of Endothelial Enhancers Reveals a Multifunctional Role for NR2F2 in Regulation of Arteriovenous Gene Expression.
Sissaoui S; Yu J; Yan A; Li R; Yukselen O; Kucukural A; Zhu LJ; Lawson ND
Circ Res; 2020 Mar; 126(7):875-888. PubMed ID: 32065070
[TBL] [Abstract][Full Text] [Related]
4. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
[TBL] [Abstract][Full Text] [Related]
5. VE-statin/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2.
Le Bras A; Samson C; Trentini M; Caetano B; Lelievre E; Mattot V; Beermann F; Soncin F
PLoS One; 2010 Aug; 5(8):e12156. PubMed ID: 20808444
[TBL] [Abstract][Full Text] [Related]
6. GATA2 regulates mast cell identity and responsiveness to antigenic stimulation by promoting chromatin remodeling at super-enhancers.
Li Y; Gao J; Kamran M; Harmacek L; Danhorn T; Leach SM; O'Connor BP; Hagman JR; Huang H
Nat Commun; 2021 Jan; 12(1):494. PubMed ID: 33479210
[TBL] [Abstract][Full Text] [Related]
7. Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer.
Todorova K; Metodiev MV; Metodieva G; Mincheff M; Fernández N; Hayrabedyan S
Horm Cancer; 2017 Feb; 8(1):28-48. PubMed ID: 28050800
[TBL] [Abstract][Full Text] [Related]
8. Retention of Interstitial Genes between
Murphy SJ; Kosari F; Karnes RJ; Nasir A; Johnson SH; Gaitatzes AG; Smadbeck JB; Rangel LJ; Vasmatzis G; Cheville JC
Cancer Res; 2017 Nov; 77(22):6157-6167. PubMed ID: 29127096
[No Abstract] [Full Text] [Related]
9. TMPRSS2-ERG fusion protein regulates insulin-like growth factor-1 receptor (IGF1R) gene expression in prostate cancer: involvement of transcription factor Sp1.
Meisel Sharon S; Pozniak Y; Geiger T; Werner H
Oncotarget; 2016 Aug; 7(32):51375-51392. PubMed ID: 27285981
[TBL] [Abstract][Full Text] [Related]
10. A non-coding genetic variant associated with abdominal aortic aneurysm alters ERG gene regulation.
Marsman J; Gimenez G; Day RC; Horsfield JA; Jones GT
Hum Mol Genet; 2020 Mar; 29(4):554-565. PubMed ID: 31691800
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor Erg controls endothelial cell quiescence by repressing activity of nuclear factor (NF)-κB p65.
Dryden NH; Sperone A; Martin-Almedina S; Hannah RL; Birdsey GM; Khan ST; Layhadi JA; Mason JC; Haskard DO; Göttgens B; Randi AM
J Biol Chem; 2012 Apr; 287(15):12331-42. PubMed ID: 22337883
[TBL] [Abstract][Full Text] [Related]
12. HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers.
Di Giorgio E; Paluvai H; Dalla E; Ranzino L; Renzini A; Moresi V; Minisini M; Picco R; Brancolini C
Genome Biol; 2021 May; 22(1):129. PubMed ID: 33966634
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions.
Singareddy R; Semaan L; Conley-Lacomb MK; St John J; Powell K; Iyer M; Smith D; Heilbrun LK; Shi D; Sakr W; Cher ML; Chinni SR
Mol Cancer Res; 2013 Nov; 11(11):1349-61. PubMed ID: 23918819
[TBL] [Abstract][Full Text] [Related]
14. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
[TBL] [Abstract][Full Text] [Related]
15. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers.
Khan A; Mathelier A; Zhang X
Epigenetics; 2018; 13(9):910-922. PubMed ID: 30169995
[TBL] [Abstract][Full Text] [Related]
16. Expanding the effects of ERG on chromatin landscapes and dysregulated transcription in prostate cancer.
Babu D; Fullwood MJ
Nat Genet; 2017 Aug; 49(9):1294-1295. PubMed ID: 28854182
[TBL] [Abstract][Full Text] [Related]
17. TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer.
Swanson TA; Krueger SA; Galoforo S; Thibodeau BJ; Martinez AA; Wilson GD; Marples B
Prostate; 2011 Oct; 71(14):1548-58. PubMed ID: 21394739
[TBL] [Abstract][Full Text] [Related]
18. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.
Bose R; Karthaus WR; Armenia J; Abida W; Iaquinta PJ; Zhang Z; Wongvipat J; Wasmuth EV; Shah N; Sullivan PS; Doran MG; Wang P; Patruno A; Zhao Y; ; Zheng D; Schultz N; Sawyers CL
Nature; 2017 Jun; 546(7660):671-675. PubMed ID: 28614298
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
[TBL] [Abstract][Full Text] [Related]
20. Significance of the TMPRSS2:ERG gene fusion in prostate cancer.
Wang Z; Wang Y; Zhang J; Hu Q; Zhi F; Zhang S; Mao D; Zhang Y; Liang H
Mol Med Rep; 2017 Oct; 16(4):5450-5458. PubMed ID: 28849022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
